Alendronate
|
Formation of non-absorbable complexes
|
Ciprofloxacin
|
Formation of non-absorbable complexes
|
Clodronate
|
Formation of non-absorbable complexes
|
Deferiprone
|
Deferiprone may decrease gastrointestinal absorption by chelating to other ions. Interaction is significant so monitor closely.
|
Demeclocycline
|
Formation of non-absorbable complexes
|
Doxycycline
|
Formation of non-absorbable complexes
|
Eltrombopag
|
Levels of eltrombopag are decreased due to GI inhibition. Separate administration by at least 4 hours.
|
Enoxacin
|
Formation of non-absorbable complexes
|
Etidronic acid
|
Formation of non-absorbable complexes
|
Gatifloxacin
|
Formation of non-absorbable complexes
|
Gemifloxacin
|
Formation of non-absorbable complexes
|
Grepafloxacin
|
Formation of non-absorbable complexes
|
Ibandronate
|
Formation of non-absorbable complexes
|
Levodopa
|
Iron decreases the absorption of dopa derivatives
|
Levofloxacin
|
Formation of non-absorbable complexes
|
Levothyroxine
|
Iron decreases the absorption of levothyroxine
|
Lomefloxacin
|
Formation of non-absorbable complexes
|
Methacycline
|
Formation of non-absorbable complexes
|
Methyldopa
|
Iron decreases the absorption of dopa derivatives
|
Minocycline
|
Formation of non-absorbable complexes
|
Moxifloxacin
|
Formation of non-absorbable complexes
|
Mycophenolate mofetil
|
Oral iron decreases the absorption of mycophenolate-mofetil
|
Norfloxacin
|
Formation of non-absorbable complexes
|
Ofloxacin
|
Formation of non-absorbable complexes
|
Oxytetracycline
|
Formation of non-absorbable complexes
|
Pefloxacin
|
Formation of non-absorbable complexes
|
Penicillamine
|
The multivalent agent decreases the effect of penicillamine
|
Risedronate
|
Formation of non-absorbable complexes
|
Temafloxacin
|
Formation of non-absorbable complexes
|
Tetracycline
|
Formation of non-absorbable complexes
|
Trovafloxacin
|
Formation of non-absorbable complexes
|